DK2240490T3 - Organiske forbindelser - Google Patents

Organiske forbindelser

Info

Publication number: DK2240490T3
Authority: DK; Denmark
Prior art keywords: organic compounds; compounds; organic
Prior art date: 2007-12-06

Application number

DK08860360.0T

Other languages

English (en)

Inventor

Peng Li

Original Assignee

Takeda Pharmaceutical

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2007-12-06

Filing date

2008-12-06

Publication date

2013-12-16

2008-12-06 Application filed by Takeda Pharmaceutical filed Critical Takeda Pharmaceutical

2013-12-16 Application granted granted Critical

2013-12-16 Publication of DK2240490T3 publication Critical patent/DK2240490T3/da

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
- C07D487/14—Ortho-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/06—Antiabortive agents; Labour repressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/14—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing aromatic rings

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Neurosurgery (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Endocrinology (AREA)
Immunology (AREA)
Reproductive Health (AREA)
Pulmonology (AREA)
Psychiatry (AREA)
Epidemiology (AREA)
Rheumatology (AREA)
Pain & Pain Management (AREA)
Gynecology & Obstetrics (AREA)
Cardiology (AREA)
Urology & Nephrology (AREA)
Physical Education & Sports Medicine (AREA)
Heart & Thoracic Surgery (AREA)
Orthopedic Medicine & Surgery (AREA)
Pregnancy & Childbirth (AREA)
Diabetes (AREA)
Psychology (AREA)
Hospice & Palliative Care (AREA)
Addiction (AREA)
Vascular Medicine (AREA)
Otolaryngology (AREA)
Anesthesiology (AREA)

DK08860360.0T 2007-12-06 2008-12-06 Organiske forbindelser DK2240490T3 (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US1204007P	2007-12-06	2007-12-06
PCT/US2008/013411 WO2009075784A1 (en)	2007-12-06	2008-12-06	Organic compounds

Publications (1)

Publication Number	Publication Date
DK2240490T3 true DK2240490T3 (da)	2013-12-16

Family

ID=40755776

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK08860360.0T DK2240490T3 (da)	2007-12-06	2008-12-06	Organiske forbindelser

Country Status (17)

Country	Link
US (3)	US8273751B2 (da)
EP (3)	EP2939676A1 (da)
JP (4)	JP5068857B2 (da)
KR (2)	KR101227738B1 (da)
CN (7)	CN104402893A (da)
AU (1)	AU2008335811B2 (da)
CA (2)	CA2845454C (da)
DK (1)	DK2240490T3 (da)
ES (1)	ES2436780T3 (da)
HK (6)	HK1207628A1 (da)
HR (1)	HRP20131073T1 (da)
IL (2)	IL206096A (da)
MX (1)	MX2010006212A (da)
PL (1)	PL2240490T3 (da)
PT (1)	PT2240490E (da)
SI (1)	SI2240490T1 (da)
WO (1)	WO2009075784A1 (da)

Families Citing this family (56)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
IL160307A0 (en)	2001-08-31	2004-07-25	Univ Rockefeller	Phosphodiesterase activity and regulation of phosphodiesterase 1-b-mediated signaling in brain
KR20140022114A (ko)	2005-06-06	2014-02-21	다케다 야쿠힌 고교 가부시키가이샤	유기 화합물
WO2007143705A2 (en)	2006-06-06	2007-12-13	Intra-Cellular Therapies, Inc.	Organic compounds
US9198924B2 (en) *	2006-11-13	2015-12-01	Intra-Cellular Therapies, Inc.	Organic compounds
US9006258B2 (en)	2006-12-05	2015-04-14	Intra-Cellular Therapies, Inc.	Method of treating female sexual dysfunction with a PDE1 inhibitor
ES2436780T3 (es)	2007-12-06	2014-01-07	Takeda Pharmaceutical Company Limited	Compuestos orgánicos
CN101969774A (zh) *	2007-12-06	2011-02-09	细胞内治疗公司	有机化合物
US20120070443A1 (en) *	2008-12-02	2012-03-22	University Of Utah Research Foundation	Pde1 as a target therapeutic in heart disease
CN102231953A (zh)	2008-12-06	2011-11-02	细胞内治疗公司	有机化合物
US8697710B2 (en)	2008-12-06	2014-04-15	Intra-Cellular Therapies, Inc.	Optionally substituted 3-amino-4-(thioxo or imino)-4,5-dihydro-2H-pyrazolo [3,4-d]pyrimidin-6(7H)-ones
JP5989993B2 (ja)	2008-12-06	2016-09-07	イントラ−セルラー・セラピーズ・インコーポレイテッドＩｎｔｒａ−ＣｅｌｌｕｌａｒＴｈｅｒａｐｉｅｓ，Ｉｎｃ．	有機化合物
KR20110103949A (ko)	2008-12-06	2011-09-21	인트라-셀룰라 써래피스, 인코퍼레이티드.	유기 화합물
EA201170772A1 (ru)	2008-12-06	2012-03-30	Интра-Селлулар Терапиз, Инк.	Органические соединения
CA2740385A1 (en)	2008-12-06	2010-06-10	Intra-Cellular Therapies, Inc.	Organic compounds
EP2400970A4 (en)	2009-02-25	2012-07-18	Intra Cellular Therapies Inc	PDE-1-HEMMER FOR EYE DRESSING
JP2012526810A (ja)	2009-05-13	2012-11-01	イントラ−セルラー・セラピーズ・インコーポレイテッド	有機化合物
WO2011016861A2 (en)	2009-08-05	2011-02-10	Intra-Cellular Therapies, Inc.	Novel regulatory proteins and inhibitors
EP2485771A4 (en)	2009-10-08	2014-11-12	Intra Cellular Therapies Inc	TRACER AND METHODS TAGGED ON PHOSPHODIESTERASE 1
WO2011153136A1 (en)	2010-05-31	2011-12-08	Intra-Cellular Therapies, Inc.	Organic compounds
WO2011153138A1 (en)	2010-05-31	2011-12-08	Intra-Cellular Therapies, Inc.	Organic compounds
TW201206937A (en)	2010-05-31	2012-02-16	Intra Cellular Therapies Inc	Organic compounds
WO2011153135A1 (en) *	2010-05-31	2011-12-08	Intra-Cellular Therapies, Inc.	Organic compounds
US10561656B2 (en)	2011-06-10	2020-02-18	Intra-Cellular Therapies, Inc.	Organic compounds
SG11201408397SA (en)	2012-06-18	2015-01-29	Dart Neuroscience Cayman Ltd	Substituted thiophene- and furan-fused azolopyrimidine-5-(6h)-one compounds
AR091507A1 (es) *	2012-06-21	2015-02-11	Intra Cellular Therapies Inc	SALES DE (6aR,9aS)-5,6a,7,8,9,9a-HEXAHIDRO-5-METIL-3-(FENILAMINO)-2-((4-(6-FLUOROPIRIDIN-2-IL)FENIL)METIL)-CICLOPENT[4,5]IMIDAZO[1,2-a]PIRAZOLO[4,3-e]PIRIMIDIN-4(2H)-ONA
EP2956141A4 (en) *	2013-02-17	2016-10-26	Intra Cellular Therapies Inc	NEW USES
MX378194B (es)	2013-03-15	2025-03-10	Intra Cellular Therapies Inc	Compuestos organicos.
US9545406B2 (en)	2013-03-15	2017-01-17	Intra-Cellular Therapies, Inc.	Method of treating a CNS injury with a PDE1 inhibitor
CN110498800A (zh) *	2013-06-21	2019-11-26	细胞内治疗公司	游离碱晶体
US9849132B2 (en)	2014-01-08	2017-12-26	Intra-Cellular Therapies, Inc.	Products and pharmaceutical compositions
US9884872B2 (en)	2014-06-20	2018-02-06	Intra-Cellular Therapies, Inc.	Organic compounds
US9938284B2 (en)	2014-08-07	2018-04-10	Intra-Cellular Therapies, Inc.	Organic compounds
US9546175B2 (en)	2014-08-07	2017-01-17	Intra-Cellular Therapies, Inc.	Organic compounds
JP6591530B2 (ja)	2014-08-07	2019-10-16	イントラ−セルラー・セラピーズ・インコーポレイテッドＩｎｔｒａ−ＣｅｌｌｕｌａｒＴｈｅｒａｐｉｅｓ，Ｉｎｃ．	有機化合物
US10285992B2 (en)	2014-08-07	2019-05-14	Intra-Cellular Therapies, Inc.	Combinations of PDE1 inhibitors and NEP inhibitors and associated methods
WO2016022836A1 (en)	2014-08-07	2016-02-11	Intra-Cellular Therapies, Inc.	Organic compounds
KR102332957B1 (ko)	2014-09-17	2021-11-29	인트라-셀룰라 써래피스, 인코퍼레이티드.	화합물 및 방법
HK1243936A1 (zh)	2014-12-06	2018-07-27	Intra-Cellular Therapies, Inc.	有机化合物
AU2015357498B2 (en)	2014-12-06	2019-09-12	Intra-Cellular Therapies, Inc.	Organic compounds
WO2016154081A1 (en) *	2015-03-26	2016-09-29	Merck Sharp & Dohme Corp.	Pyrazolyl pyrimidinone compounds as pde2 inhibitors
US10682354B2 (en)	2016-03-28	2020-06-16	Intra-Cellular Therapies, Inc.	Compositions and methods
ES2906107T3 (es)	2016-09-12	2022-04-13	Intra Cellular Therapies Inc	Usos novedosos
MX390582B (es)	2016-12-28	2025-03-20	Dart Neuroscience Llc Star	Compuestos de pirazolopirimidinona sustituida como inhibidores de fosfodiesterasas 2 (pde2)
KR102794907B1 (ko)	2017-11-27	2025-04-14	다트 뉴로사이언스, 엘엘씨	Pde1 억제제로서의 치환된 푸라노피리미딘 화합물
US11839614B2 (en)	2018-01-31	2023-12-12	Intra-Cellular Therapies, Inc.	Methods for treating or mitigating cardiotoxicity characterized by inhibition of adenosine A2 signaling and/or adenosine A2 receptor expression
KR20210013214A (ko)	2018-05-25	2021-02-03	인트라-셀룰라 써래피스, 인코퍼레이티드.	유기 화합물
BR112021007571A2 (pt) *	2018-10-21	2021-07-27	Intra-Cellular Therapies, Inc.	novos usos
US12396992B2 (en)	2019-01-07	2025-08-26	Intra-Cellular Therapies, Inc.	Organic compounds
US11628171B2 (en)	2019-03-13	2023-04-18	Children's Medical Center Corporation	Method for treating brain or nerve injury
EP3953358A4 (en) *	2019-04-12	2023-01-04	Intra-Cellular Therapies, Inc.	ORGANIC COMPOUNDS
JP7612672B2 (ja)	2019-09-03	2025-01-14	イントラ－セルラー・セラピーズ・インコーポレイテッド	新規化合物
US20230355625A1 (en) *	2019-11-27	2023-11-09	Intra-Cellular Therapies, Inc.	Methods of treatment
WO2021226407A1 (en)	2020-05-06	2021-11-11	Intra-Cellular Therapies, Inc.	Free base crystals
US12364695B2 (en) *	2020-06-02	2025-07-22	Intra-Cellular Therapies, Inc.	Methods of treating inflammatory disease
EP4395767A4 (en) *	2021-09-03	2025-07-23	Intra Cellular Therapies Inc	CO-CRYSTALS
EP4472638A2 (en) *	2022-01-31	2024-12-11	Intra-Cellular Therapies, Inc.	Salt crystals

Family Cites Families (45)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4666908A (en)	1985-04-05	1987-05-19	Warner-Lambert Company	5-Substituted pyrazolo[4,3-d]pyrimidine-7-ones and methods of use
KR920004437B1 (ko)	1989-09-12	1992-06-05	삼성전자 주식회사	금전등록기의 거래선 관리방법
IL98559A0 (en)	1990-06-21	1992-07-15	Schering Corp	Polycyclic guanine derivatives
US5294612A (en)	1992-03-30	1994-03-15	Sterling Winthrop Inc.	6-heterocyclyl pyrazolo [3,4-d]pyrimidin-4-ones and compositions and method of use thereof
CN1118600A (zh)	1993-02-26	1996-03-13	先灵公司	2-苄基-多环鸟嘌呤衍生物以及制备它们的方法
US5824683A (en)	1995-11-28	1998-10-20	Schering Corporation	2'- 4'-halo- 1,1'-biphenyl!-4-yl!methyl!-5'-methyl-spiro cyclopentane-1,7' (8'H)- 3H! imidazo 2,1-b!purin!-4' (5'H)-ones
SE9701398D0 (sv)	1997-04-15	1997-04-15	Astra Pharma Prod	Novel compounds
IT1291372B1 (it)	1997-05-21	1999-01-07	Schering Plough S P A	Uso di analoghi eterociclici di 1,2,4-triazolo (1,5-c) pirimidine per la preparazione di medicamenti utili per il trattamento delle malattie
US6013621A (en)	1997-10-17	2000-01-11	The Rockfeller University	Method of treating psychosis and/or hyperactivity
GB9722520D0 (en)	1997-10-24	1997-12-24	Pfizer Ltd	Compounds
DE19931206A1 (de)	1999-07-07	2001-01-11	Stief Christian	Arzneimittel zur Erhöhung des cAMP-Spiegels und deren Verwendung
EA200200240A1 (ru)	1999-10-11	2002-10-31	Пфайзер Инк.	5-(2-ЗАМЕЩЕННЫЕ-5-ГЕТЕРОЦИКЛИЛСУЛЬФОНИЛПИРИД-3-ИЛ)-ДИГИДРОПИРАЗОЛО[4,3-d]ПИРИМИДИН-7-ОНЫ В КАЧЕСТВЕ ИНГИБИТОРОВ ФОСФОДИЭСТЕРАЗЫ
IL152925A (en) *	1999-10-21	2010-04-15	Pfizer	Pharmaceutical preparations for the treatment of neurological disease containing an inhibitor of ring guanizine '3', 5 '- monophosphate phosphodiesterase 5 and one of gabapentin or pregabalin
JP2004500425A (ja)	2000-04-19	2004-01-08	リリー　アイコス　リミテッド　ライアビリティ　カンパニー	パーキンソン病の処置に対する環状ｇｍｐ特異的ホスホジエステラーゼインヒビターの使用
SE0102315D0 (sv)	2001-06-28	2001-06-28	Astrazeneca Ab	Compounds
EP1421084B1 (en)	2001-08-28	2008-05-14	Schering Corporation	Polycyclic guanine phosphodiesterase v inhibitors
IL160307A0 (en)	2001-08-31	2004-07-25	Univ Rockefeller	Phosphodiesterase activity and regulation of phosphodiesterase 1-b-mediated signaling in brain
WO2003042216A1 (en)	2001-11-09	2003-05-22	Schering Corporation	Polycyclic guanine derivative phosphodiesterase v inhibitors
AU2003219838B2 (en)	2002-02-21	2007-09-13	The Rockefeller University	Compositions and method for regulation of calcium-dependent signalling in brain
EP1613747A1 (en)	2003-03-31	2006-01-11	Pfizer Products Inc.	Crystal structure of 3 ,5 -cyclic nucleotide phosphodiesterase 1b (pde1b) and uses thereof
WO2004087211A2 (en) *	2003-04-01	2004-10-14	Applied Research Systems Ars Holding N.V.	Inhibitors of phosphodiesterases in infertility
ZA200507228B (en) *	2003-04-01	2007-03-28	Applied Research Systems	Inhibitors of phosphodiesterases in infertility
KR20140022114A (ko)	2005-06-06	2014-02-21	다케다 야쿠힌 고교 가부시키가이샤	유기 화합물
US20080194592A1 (en)	2005-08-23	2008-08-14	Intra-Cellular Therapies, Inc.	Organic Compounds
WO2007143705A2 (en)	2006-06-06	2007-12-13	Intra-Cellular Therapies, Inc.	Organic compounds
US9198924B2 (en)	2006-11-13	2015-12-01	Intra-Cellular Therapies, Inc.	Organic compounds
US9006258B2 (en)	2006-12-05	2015-04-14	Intra-Cellular Therapies, Inc.	Method of treating female sexual dysfunction with a PDE1 inhibitor
ES2436780T3 (es) *	2007-12-06	2014-01-07	Takeda Pharmaceutical Company Limited	Compuestos orgánicos
CN101969774A (zh)	2007-12-06	2011-02-09	细胞内治疗公司	有机化合物
EA201170772A1 (ru)	2008-12-06	2012-03-30	Интра-Селлулар Терапиз, Инк.	Органические соединения
CA2740385A1 (en)	2008-12-06	2010-06-10	Intra-Cellular Therapies, Inc.	Organic compounds
CN102231953A (zh)	2008-12-06	2011-11-02	细胞内治疗公司	有机化合物
US8697710B2 (en)	2008-12-06	2014-04-15	Intra-Cellular Therapies, Inc.	Optionally substituted 3-amino-4-(thioxo or imino)-4,5-dihydro-2H-pyrazolo [3,4-d]pyrimidin-6(7H)-ones
JP5989993B2 (ja)	2008-12-06	2016-09-07	イントラ−セルラー・セラピーズ・インコーポレイテッドＩｎｔｒａ−ＣｅｌｌｕｌａｒＴｈｅｒａｐｉｅｓ，Ｉｎｃ．	有機化合物
KR20110103949A (ko)	2008-12-06	2011-09-21	인트라-셀룰라 써래피스, 인코퍼레이티드.	유기 화합물
EP2400970A4 (en)	2009-02-25	2012-07-18	Intra Cellular Therapies Inc	PDE-1-HEMMER FOR EYE DRESSING
JP2012526810A (ja) *	2009-05-13	2012-11-01	イントラ−セルラー・セラピーズ・インコーポレイテッド	有機化合物
EP2485771A4 (en)	2009-10-08	2014-11-12	Intra Cellular Therapies Inc	TRACER AND METHODS TAGGED ON PHOSPHODIESTERASE 1
TW201206937A (en)	2010-05-31	2012-02-16	Intra Cellular Therapies Inc	Organic compounds
WO2011153136A1 (en)	2010-05-31	2011-12-08	Intra-Cellular Therapies, Inc.	Organic compounds
WO2011153138A1 (en)	2010-05-31	2011-12-08	Intra-Cellular Therapies, Inc.	Organic compounds
WO2011153135A1 (en)	2010-05-31	2011-12-08	Intra-Cellular Therapies, Inc.	Organic compounds
US10561656B2 (en)	2011-06-10	2020-02-18	Intra-Cellular Therapies, Inc.	Organic compounds
AR091507A1 (es)	2012-06-21	2015-02-11	Intra Cellular Therapies Inc	SALES DE (6aR,9aS)-5,6a,7,8,9,9a-HEXAHIDRO-5-METIL-3-(FENILAMINO)-2-((4-(6-FLUOROPIRIDIN-2-IL)FENIL)METIL)-CICLOPENT[4,5]IMIDAZO[1,2-a]PIRAZOLO[4,3-e]PIRIMIDIN-4(2H)-ONA
MX378194B (es)	2013-03-15	2025-03-10	Intra Cellular Therapies Inc	Compuestos organicos.

2008
- 2008-12-06 ES ES08860360.0T patent/ES2436780T3/es active Active
- 2008-12-06 PT PT88603600T patent/PT2240490E/pt unknown
- 2008-12-06 HR HRP20131073AT patent/HRP20131073T1/hr unknown
- 2008-12-06 CN CN201410545375.6A patent/CN104402893A/zh active Pending
- 2008-12-06 AU AU2008335811A patent/AU2008335811B2/en active Active
- 2008-12-06 JP JP2010536936A patent/JP5068857B2/ja active Active
- 2008-12-06 US US12/746,236 patent/US8273751B2/en active Active
- 2008-12-06 CN CN201410545465.5A patent/CN104370919A/zh active Pending
- 2008-12-06 SI SI200831099T patent/SI2240490T1/sl unknown
- 2008-12-06 CN CN201410545499.4A patent/CN104370920A/zh active Pending
- 2008-12-06 MX MX2010006212A patent/MX2010006212A/es active IP Right Grant
- 2008-12-06 CN CN201410545509.4A patent/CN104370921A/zh active Pending
- 2008-12-06 CN CN201410545520.0A patent/CN104370922A/zh active Pending
- 2008-12-06 DK DK08860360.0T patent/DK2240490T3/da active
- 2008-12-06 WO PCT/US2008/013411 patent/WO2009075784A1/en not_active Ceased
- 2008-12-06 EP EP15152132.5A patent/EP2939676A1/en not_active Withdrawn
- 2008-12-06 CA CA2845454A patent/CA2845454C/en active Active
- 2008-12-06 CN CN201410545406.8A patent/CN104370918A/zh active Pending
- 2008-12-06 EP EP13177860.7A patent/EP2698160A3/en not_active Withdrawn
- 2008-12-06 EP EP08860360.0A patent/EP2240490B1/en active Active
- 2008-12-06 CN CN2008801262362A patent/CN101970444A/zh active Pending
- 2008-12-06 KR KR1020107014663A patent/KR101227738B1/ko active Active
- 2008-12-06 CA CA2707349A patent/CA2707349C/en active Active
- 2008-12-06 PL PL08860360T patent/PL2240490T3/pl unknown
- 2008-12-06 KR KR1020117029449A patent/KR20120012831A/ko not_active Ceased
2010
- 2010-05-31 IL IL206096A patent/IL206096A/en active IP Right Grant
2012
- 2012-04-19 JP JP2012095588A patent/JP5536135B2/ja active Active
- 2012-06-01 US US13/486,264 patent/US8829008B2/en active Active
2014
- 2014-03-24 IL IL231674A patent/IL231674A0/en unknown
- 2014-04-23 JP JP2014089334A patent/JP2014148534A/ja active Pending
- 2014-08-15 US US14/461,132 patent/US9403836B2/en active Active
2015
- 2015-08-25 HK HK15108239.7A patent/HK1207628A1/xx active IP Right Revival
- 2015-08-25 HK HK15108238.8A patent/HK1207627A1/xx unknown
- 2015-08-25 HK HK15108241.3A patent/HK1207629A1/xx active IP Right Revival
- 2015-08-25 HK HK15108243.1A patent/HK1207631A1/xx unknown
- 2015-08-25 HK HK15108242.2A patent/HK1207630A1/xx unknown
- 2015-09-10 HK HK15108825.7A patent/HK1208218A1/xx active IP Right Revival
- 2015-10-14 JP JP2015203116A patent/JP2016190834A/ja active Pending

Also Published As

Publication number	Publication date
CN104370922A (zh)	2015-02-25
JP2016190834A (ja)	2016-11-10
PL2240490T3 (pl)	2014-02-28
HK1207627A1 (en)	2016-02-05
US8829008B2 (en)	2014-09-09
IL206096A0 (en)	2010-11-30
EP2698160A3 (en)	2014-07-23
KR20120012831A (ko)	2012-02-10
CA2707349C (en)	2014-05-27
MX2010006212A (es)	2010-08-10
JP2011506321A (ja)	2011-03-03
CA2707349A1 (en)	2009-06-18
IL231674A0 (en)	2014-04-30
AU2008335811B2 (en)	2012-05-17
JP5068857B2 (ja)	2012-11-07
WO2009075784A1 (en)	2009-06-18
JP2014148534A (ja)	2014-08-21
HK1207628A1 (en)	2016-02-05
IL206096A (en)	2014-04-30
US9403836B2 (en)	2016-08-02
EP2240490A4 (en)	2011-06-15
US20120238589A1 (en)	2012-09-20
JP5536135B2 (ja)	2014-07-02
KR101227738B1 (ko)	2013-01-29
CN104370921A (zh)	2015-02-25
JP2012167099A (ja)	2012-09-06
AU2008335811A1 (en)	2009-06-18
US20100273754A1 (en)	2010-10-28
HK1207630A1 (en)	2016-02-05
EP2240490B1 (en)	2013-09-04
HK1207629A1 (en)	2016-02-05
CN104370919A (zh)	2015-02-25
EP2698160A2 (en)	2014-02-19
HK1208218A1 (en)	2016-02-26
PT2240490E (pt)	2013-12-09
EP2939676A1 (en)	2015-11-04
HRP20131073T1 (hr)	2014-01-31
CN104370918A (zh)	2015-02-25
SI2240490T1 (sl)	2014-02-28
EP2240490A1 (en)	2010-10-20
CN101970444A (zh)	2011-02-09
US20140357606A1 (en)	2014-12-04
CA2845454C (en)	2017-02-07
CN104370920A (zh)	2015-02-25
ES2436780T3 (es)	2014-01-07
CN104402893A (zh)	2015-03-11
HK1207631A1 (en)	2016-02-05
CA2845454A1 (en)	2009-06-18
US8273751B2 (en)	2012-09-25
KR20100102138A (ko)	2010-09-20

Publication	Publication Date	Title
DK2240490T3 (da)	2013-12-16	Organiske forbindelser
BRPI0817434A2 (pt)	2015-06-16	Composto orgânicos
BRPI0811562A2 (pt)	2014-12-09	Compostos orgânicos
BRPI0922351A2 (pt)	2018-06-05	compostos orgânicos
BRPI0922700A2 (pt)	2015-08-11	Compostos orgânicos
BRPI0922131A2 (pt)	2015-08-18	Compostos orgânicos
BRPI0922808A2 (pt)	2018-05-29	compostos orgânicos
BRPI0922809A2 (pt)	2018-05-29	compostos orgânicos
BRPI0922348A2 (pt)	2015-08-11	Compostos orgânicos
BRPI0913966A2 (pt)	2015-11-17	compostos orgânicos
BRPI0914698A2 (pt)	2015-10-20	compostos orgânicos
BRPI0909417A2 (pt)	2015-12-08	compostos orgânicos
BRPI0915018A2 (pt)	2015-10-27	compostos orgânicos
BRPI0718874A2 (pt)	2015-06-23	Compostos orgânicos
NO20084803L (no)	2008-11-19	organiske forbindelser
BRPI0718478A2 (pt)	2013-11-26	Compostos orgânicos
DK2310359T3 (da)	2014-04-07	Organiske forbindelser
BRPI0917574A2 (pt)	2015-11-17	compostos orgânicos
BRPI0921826A2 (pt)	2016-01-12	compostos orgânicos
BRPI0907611A2 (pt)	2015-07-21	Compostos orgânicos
BRPI0821401A2 (pt)	2014-10-14	Compostos orgânicos
BRPI0813500A2 (pt)	2015-01-06	Compostos antivirais
DK2185567T3 (da)	2011-05-16	Substituerede bicyclolactam-forbindelser
BRPI0821086A2 (pt)	2014-10-07	Compostos inseticidas
BRPI0712902A2 (pt)	2018-10-30	compostos orgânicos